Hytisone

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hytisone

Property Description
Active Ingredient Hydrocortisone (INN)
Form Tablets, Injections, Topical Creams/Ointments
Pharmacological Class Corticosteroid (Glucocorticoid)
Common Use Hormone replacement therapy; Anti-inflammatory agent
Origin Synthetic derivative of natural Cortisol
Differentiating Feature Standard short-acting Glucocorticoid with balanced mineralocorticoid activity

What Type of Medicine is Hytisone?

Hytisone is a trade name for the active pharmaceutical ingredient Hydrocortisone, which is chemically classified as a powerful corticosteroid. This drug belongs to the specific pharmacological class of Glucocorticoids, essential substances for managing the body's immune and inflammatory responses. Hydrocortisone is a primary agent used for managing inflammation and autoimmune conditions. This property is clinically recognized for providing a swift onset of action in mitigating swelling and immune overactivity in affected tissues.

The compound is a precise synthetic derivative of Cortisol, the natural glucocorticoid hormone produced by the adrenal glands. Hydrocortisone is distinctly known among its class for being the shortest-acting glucocorticoid with significant, balanced mineralocorticoid activity, a feature essential for fluid and electrolyte regulation. Because it is functionally identical to the body's own Cortisol, it is used to replace the body's deficient natural production in cases of adrenal insufficiency.

Composition and Available Forms of Hydrocortisone

The medicinal entity is a single-ingredient product, meaning Hydrocortisone is the sole therapeutically active component. This active ingredient is prepared with an inert pharmaceutical base appropriate for its intended route of administration, which determines if the product is available as a prescription-only medicine (Rx) or over-the-counter (OTC) in lower topical strengths.

Hydrocortisone is manufactured into several high-level dosage forms to suit different clinical needs, including tablets for oral, systemic absorption, solutions for injection (intramuscular or intravenous) for acute care, and various topical preparations such as creams, ointments, and lotions for localized effects.

General Therapeutic Purpose of this Glucocorticoid

The general purpose of this medication is to effectively control inflammation and address deficiencies in natural hormone levels. Its powerful action is rooted in its ability to modulate the immune system, leading to a significant immunosuppressive effect and marked anti-inflammatory action.

By regulating the body’s inflammatory cascade, Hytisone helps relieve the key symptoms associated with inflammation, such as swelling, localized pain, and heat. A typical scenario involves the use of a topical Hydrocortisone preparation to control temporary, localized skin irritation. Furthermore, its ability to perfectly replace natural Cortisol means it is vital for maintaining metabolic stability and physiological balance in patients who require hormone replacement therapy.

Regulatory References

  1. NIH MedlinePlus on Hydrocortisone
  2. WHO Essential Medicines List recommendation for Hydrocortisone

What side effects are possible with Hytisone?

Hytisone (Hydrocortisone) is associated with officially documented adverse reactions that are categorized by the organ system affected, as outlined in government regulatory documents.

Adverse Reaction Classifications

Adverse effects are documented across multiple System-Organ Classes, including the Musculoskeletal system (e.g., muscle weakness, osteoporosis), Gastrointestinal system (e.g., peptic ulcer, abdominal distention), Dermatologic system (e.g., thinning fragile skin, impaired wound healing), and Neuropsychiatric system (e.g., mood swings, insomnia, depression, or psychosis) [FDA DailyMed]. Effects on Fluid and Electrolyte balance, such as sodium retention and potassium loss, are also officially listed.

Timing and Serious Adverse Reactions

Specific side effects are linked to treatment duration and timing. The development of clinical features resembling Cushing’s syndrome, posterior subcapsular cataracts, and glaucoma is primarily associated with long-term exposure to higher-than-replacement doses [EMA Plenadren]. Adrenocortical insufficiency, a serious reaction, is a risk upon abrupt withdrawal or stress. Other serious adverse reactions include peptic ulcer with possible perforation and hemorrhage [FDA Cortef].

Population and Safety Notes

Regulatory documents include specific safety considerations for patient groups. In the pediatric population, there is an officially documented risk of suppressed linear growth [FDA DailyMed]. Regarding safety constraints, Hytisone is generally not used in individuals with uncontrolled systemic fungal infections, as this class of medicine may lead to decreased resistance to infection [FDA Solu-Cortef].

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Hytisone (Hydrocortisone) overdose describes manifestations primarily related to the effects of glucocorticoid and mineralocorticoid excess.

Documented Overdose Presentations

Acute overexposure may present with fluid and electrolyte disturbances, including salt and water retention and elevated blood pressure (Hypertension). Systemic manifestations documented in labeling include nausea and vomiting, altered mental status such as agitation, and in severe cases, convulsions (seizures).

Long-term overexposure to supra-physiological doses may lead to clinical features resembling Cushing's Syndrome. Population-specific notes indicate that children require monitoring due to the risk of slowed growth and that old age and low body mass index are risk factors for adverse reactions associated with high doses.

When to Seek Immediate Medical Help

The prescribing information mandates that immediate medical attention must be sought for any suspected overdose. Emergency services must be contacted immediately if a person is experiencing trouble breathing, has collapsed, had a seizure, or cannot be awakened.

There is no specific antidote known for Hytisone overdose. Management is symptomatic and supportive, and may include procedures such as gastric lavage, administration of activated charcoal, and correction of fluid and electrolyte changes under hospital monitoring.

Therapeutic Uses of Hytisone

What Hytisone Treats: Main Uses and Benefits


The therapeutic role of Hytisone (Hydrocortisone) is two-fold, encompassing essential hormone replacement and symptom management for inflammation. This medication is considered relevant across domains where additional symptomatic support is needed, or where a critical physiological hormone is missing. Hytisone is commonly used across conditions presenting with acute episodes and heightened symptoms, including adrenal insufficiency, rheumatoid arthritis flares, severe allergic reactions, and various inflammatory dermatologic diseases.

Essential Support for Adrenal Hormone Deficiency

Hytisone is commonly used for providing life-sustaining hormone replacement in individuals whose adrenal glands generally fail to produce adequate natural cortisol. It is applied in addressing symptom clusters related to systemic imbalance, including profound fatigue, generalized weakness, and the risk of circulatory instability. This application assists with maintaining functional stability and supports general well-being in situations where patients experience increased physiological stress.

Managing Inflammation and Acute Distress

This medication may be part of symptomatic management across therapeutic domains marked by the body's overactive immune response. It is relevant in conditions characterized by periods of heightened symptoms, helping address symptom clusters related to physical discomfort like swelling and pain. This approach provides support that helps ease the overall symptom burden, assisting patients with coping more steadily with difficult episodes.

Quick Fact: Relief for Inflammatory Symptoms
Hytisone is commonly used to help with symptoms related to inflammatory or irritative states, offering support that helps ease the overall symptom burden in conditions marked by heightened symptoms.

Regulatory References

  1. NIH DailyMed Label for Hydrocortisone

Eligibility and Restrictions for Use

Who Can and Cannot Use Hytisone?

Eligibility for Hytisone (Hydrocortisone) is strictly defined by official regulatory documents, which classify use based on specific patient populations and conditions.

Allowed and Established Use

Hytisone is permitted for individuals requiring hormone replacement therapy for adrenocortical insufficiency (primary or secondary). Use in infants and children is established for this specific replacement therapy, although safety for general use of certain oral forms is not established for the overall pediatric population.

Absolute Contraindications

The medicine is contraindicated for patients with a known hypersensitivity to Hydrocortisone or its excipients. Hytisone must not be used in individuals with systemic fungal infections or unmanaged systemic infections when receiving pharmacological doses. It is also prohibited for patients receiving live vaccines while on immunosuppressive doses.

Conditional Use and Restrictions

Use requires particular care and close monitoring for patients with comorbidities such as diabetes mellitus, hypertension, congestive heart failure, or a history of peptic ulcers. Dose adjustments and monitoring are formally required for patients with severe hepatic or renal impairment. Use during pregnancy is restricted, requiring a formal risk-benefit assessment.

What should I know about interactions with other medicines?

Hytisone Interactions with Other Medicines and Products

The official regulatory profile for Hytisone (Hydrocortisone) documents specific interaction patterns with other medicines, foods, and patient conditions.

Formal Restrictions and Prohibited Combinations

The co-administration of live or live-attenuated vaccines is formally restricted and contraindicated during treatment with immunosuppressive doses of Hytisone. The combination with Mifepristone is also noted in regulatory documents as generally not recommended due to an antagonistic effect.

Interactions Affecting Clearance and Exposure

A key interaction pattern involves pharmacokinetic interference through the CYP3A4 enzyme system. Drugs classified as CYP3A4 inhibitors (e.g., Ketoconazole, Clarithromycin) decrease Hytisone's metabolism, leading to an increased serum concentration and higher exposure. Conversely, CYP3A4 inducers (e.g., Rifampin, Phenytoin) increase Hytisone clearance, which may reduce its overall level or effect.

Pharmacodynamic and Substance Interactions

Co-administration with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may result in an additive risk of gastrointestinal adverse reactions. Combining Hytisone with Potassium-Depleting Agents like certain diuretics or Amphotericin B can enhance the risk of hypokalemia. Furthermore, consuming Grapefruit Juice is documented as potentially inhibiting metabolism and increasing Hytisone blood levels.

Population-Specific Considerations

Official labeling notes that the effect of Hytisone is enhanced in specific patient populations, including those with Hypothyroidism or Cirrhosis (liver impairment), due to decreased drug metabolism in these conditions.

Mechanism of Action

How Hytisone Works: Dual Action and Signaling Modulation


Targeting Intracellular Glucocorticoid Receptors

Hytisone acts within domains involving receptor-mediated signaling by entering cells and binding to specific cytoplasmic glucocorticoid receptors (GRs). This binding alters the receptor's conformation, allowing the complex to translocate into the nucleus where it modulates gene transcription, initiating or suppressing molecular signaling sequences that shape systemic outcomes.

Modulation of Pro-inflammatory Pathways

The drug engages mechanisms that influence inflammatory pathway activity by binding to DNA response elements and modulating the expression of inflammatory genes. This action modifies early molecular steps, leading to the suppression of pro-inflammatory mediators (like certain cytokines and enzymes such as COX-2) and promoting the production of anti-inflammatory proteins, resulting in the attenuation of mediator signaling.

Influencing Immune and Metabolic Systems

Hytisone influences the regulation of processes driven by distinct signaling patterns by inhibiting the proliferation and activity of various immune cells like T cells and macrophages. It also affects metabolic processes, such as increasing gluconeogenesis in the liver and influencing protein catabolism, modulating activity across multiple biological systems.

Dosage and Administration Information

Hytisone (Hydrocortisone) is administered via multiple routes, including oral (immediate-release and modified-release tablets), intravenous (IV), intramuscular (IM), and topical preparations.


Administration Regimens and Timing

Systemic use is defined through specific dosing and timing. For hormone replacement, the typical oral maintenance dose ranges from 15 mg to 30 mg daily, usually divided into two or three daily doses. Conversely, the intravenous dose for severe acute conditions is typically 100 mg to 500 mg per administration, which may be repeated every two to six hours.

Timing in relation to meals is important: conventional tablets should be taken with or just after food to minimize gastrointestinal discomfort. However, the modified-release tablet is taken once daily on awakening, at least 30 minutes before food intake.


Key Procedural Instructions

Administration procedures are defined by the dosage form. The sterile powder for injection must be reconstituted with a specified diluent before IV or IM use. Oral tablets designed with a specific release profile, such as the modified-release form, must be swallowed whole and must not be crushed or chewed. Doses for pediatric patients are generally calculated based on body surface area or weight, not fixed adult amounts.

A procedural condition for long-term systemic use is the requirement to gradually reduce the daily dose (tapering) before discontinuation. Furthermore, the dose is temporarily increased (up-dosed) during periods of high physiological stress, such as surgery or severe infection.

Recent Clinical Evidence

Research evidence / Overview of studies for Hytisone

This overview summarizes the available research and clinical trials for Hytisone (Hydrocortisone), focusing on the types of studies conducted and the evidence patterns that have been observed, without providing individual medical advice or making claims about guaranteed outcomes.


Research Supporting Hormone Replacement Therapy

Hytisone was studied for its use in clinical situations such as Adrenal Insufficiency, which are conditions marked by functional limitations associated with a deficiency in the body's natural cortisol. Because Hytisone is functionally identical to the natural hormone, regulatory frameworks recognize this application as the functional standard for replacement therapy. The research base includes long-term observational studies and pilot randomized controlled trials (RCTs). Studies in this area research examined outcomes related to systemic or functional imbalance, such as maintaining physiological stability, and patient-reported experiences, focusing on Quality of Life (QoL) scores and physical outcomes related to physical discomfort, like fatigue. This replacement therapy was studied for various age groups, including children and neonates who required support for temporary physiological imbalance.

Research Supporting Systemic Anti-inflammatory Use

Research has explored Hytisone in clinical settings involving conditions associated with acute or disruptive episodes, specifically among critically ill patients. The research is based on a large number of Randomized Controlled Trials (RCTs) and comprehensive meta-analyses. These studies research examined outcomes monitoring physiological strain or stress, most notably survival measured at various defined time intervals, and functional measures like the number of days a patient did not require advanced support. The research primarily focused on critically ill adult patients who were already receiving advanced life support, meaning that results apply only to the populations studied and that comparative evidence is lacking to definitively show its performance when used alone versus in combination with other agents.

Areas of Research Uncertainty and Study Limitations

The research on Hytisone provides two distinct types of duration data: long-term observational settings evaluating daily-life functioning for replacement therapy, versus a focus on short-term symptom changes for anti-inflammatory use. Evidence is limited in areas where findings from high-quality trials are inconsistent, particularly concerning the primary survival endpoints in acute settings. Follow-up durations were limited in many studies, meaning long-term patient-reported outcomes for well-being are not yet fully understood. These factors mean that research provides context but not individual predictions about the expected response.

Key Studies & References

  1. Hydrocortisone Official FDA Labeling and Patient Information (DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Hytisone (FAQ)


Q: Is Hytisone the same type of medicine as [similar sounding drug]?

Hytisone contains the active ingredient hydrocortisone, which is a powerful corticosteroid. Official information describes it as a short-acting glucocorticoid with balanced mineralocorticoid activity. This specific chemical profile helps distinguish it from other medicines within the broader corticosteroid class.


Q: How quickly does Hytisone start to have an effect?

The speed of action depends on the form used. According to the official product information, when administered intravenously for acute conditions, pharmacokinetic data indicates onset of action may be observed within about one hour. Following intravenous use, high blood levels are achieved quickly according to official data.


Q: Does Hytisone need to be taken long-term for some conditions?

Yes, regulatory documents indicate that long-term use is necessary for certain conditions. For example, if Hytisone is used for hormone replacement therapy, such as for Adrenal Insufficiency, official patient information often indicates that this is typically considered a lifelong replacement therapy.


Q: Is it common to feel [vague side effect like dizziness/nausea] when starting Hytisone?

Official documents list nausea and dizziness as potential adverse reactions that may occur with Hytisone use. However, these documents do not typically classify the frequency (common or rare) of every single effect, especially those felt when initially starting the medication.


Q: What are the most commonly reported side effects of Hytisone?

Regulatory documents list several common adverse reactions associated with systemic use. These effects include fluid retention, changes in blood glucose levels, elevation in blood pressure, an increased appetite, and weight gain.


Q: Are there any common foods or drinks that should be avoided with Hytisone?

Yes. Official product information states that grapefruit or grapefruit juice should be avoided. Grapefruit may interfere with how the body processes the medicine, which could potentially lead to higher blood levels and an increased risk of experiencing side effects.


Q: Why do official documents list so many potential side effects for Hytisone?

As a systemic corticosteroid, Hytisone is known to influence many different biological processes and organ systems. Because it affects the Musculoskeletal, Gastrointestinal, Dermatologic, and Neuropsychiatric systems, official regulatory requirements mandate that all potential adverse effects across these systems must be fully documented.


Q: Can older adults typically use Hytisone?

Regulatory documents note that the use of Hytisone in older adults is associated with requirements for caution and close monitoring. This is because older patients may be more susceptible to corticosteroid-related adverse effects, such as complications with fluid retention or existing conditions like high blood pressure.


Q: What happens if a dose of Hytisone is missed?

Official patient information indicates that missing doses frequently can lead to feeling unwell, particularly if the medicine is used for hormone replacement therapy. If a dose is missed, official guidance directs patients to seek advice from a healthcare professional.


Q: Is Hytisone habit-forming or addictive?

Hytisone is not classified by regulatory bodies as a controlled substance. However, after prolonged, continuous use of certain forms, especially strong topical preparations, reports of withdrawal reactions have been noted when the medicine is stopped, sometimes referred to in patient communities as 'topical steroid addiction.'


Q: What is the typical duration of Hytisone's effect after it is taken?

The time the drug remains in the body and its therapeutic effect can differ. Official pharmacokinetic data indicates that following intravenous administration, the drug is substantially cleared from the plasma within about 12 hours, with a plasma half-life of roughly 1.5 to 2 hours. The biological effects on the body's systems may last for a longer duration.


Q: Can Hytisone affect the results of lab tests?

Yes, according to the official product label, corticosteroids can influence the results of certain medical tests. Specifically, the medicine can potentially interfere with laboratory tests, such as those used to evaluate the function of the body's natural hormone axis, including the ACTH stimulation test.


Q: Is Hytisone available as a generic version?

Yes. The active ingredient in Hytisone, hydrocortisone, is widely available in generic versions. These include FDA-approved generic products for oral tablets, injections, and various topical formulations.


Q: Can Hytisone be taken with vitamins or dietary supplements?

Regulatory guidance focuses on interactions with medicines that affect the CYP3A4 enzyme system, which processes Hytisone. Official documents state that any supplement known to affect the CYP3A4 system, such as certain herbs, may cause a change in how Hytisone works or may alter the level of the drug in the blood.


Q: How does the action of Hytisone differ from an antibiotic?

Hytisone is a corticosteroid that primarily works by modulating the immune system to reduce inflammation and suppress immune responses. It is not an antibiotic, which acts by directly targeting or killing bacteria. In fact, Hytisone use may reduce the body's natural ability to resist new infections.


Q: What is the typical time frame to see the full effect of Hytisone?

The time required to see the full therapeutic benefit can vary significantly. It depends on the condition being addressed, such as whether it is being used for acute inflammation or for long-term hormone replacement. Even with a rapid onset, the time until maximum benefit may take several hours or days.


Q: Is it normal to feel no immediate change when taking Hytisone?

It can be normal to not feel an immediate change, depending on the reason for use. When used for long-term conditions like hormone replacement, the goal is physiological stability, and noticeable changes may be gradual rather than sudden or dramatic.


Q: What are the main ingredients in Hytisone besides the active component?

Besides the active component, hydrocortisone, the products contain inactive ingredients (known as excipients). These substances are necessary to create the final form of the medicine, such as a tablet, cream, or injection, and may include components like glycerin or stabilizers.


Q: Are there any common interactions with herbal remedies and Hytisone?

Official guidance identifies potential interactions between Hytisone and medicines that affect the CYP3A4 enzyme system. Since some herbal remedies can impact this enzyme system, using such remedies concurrently may change the required dose of Hytisone or reduce its effectiveness.


Q: What precautions are advised for women who are breastfeeding and using Hytisone?

Regulatory documentation states that the use of Hytisone during breastfeeding should be approached with caution. Official information indicates that while systemic corticosteroids may pass into breast milk, a formal risk-benefit assessment is necessary before use.


Q: Do official sources mention weight gain as a possible effect of Hytisone?

Yes. Weight gain is explicitly listed in regulatory documents as a potential common adverse reaction. It is often described in official information as being associated with an increase in appetite and fluid retention.


Q: What is the difference between a side effect and a contraindication for Hytisone?

A side effect (adverse reaction) is an unwanted physical response that may occur during use. A contraindication is a specific condition, such as a systemic fungal infection, that makes the use of Hytisone formally prohibited due to an unacceptably high risk of harm.


Q: Why is there a specific instruction about not using Hytisone for certain eye conditions?

Regulatory documents list potential ophthalmic adverse reactions. Long-term use is associated with an increased risk for the development of cataracts and glaucoma, and use in this area is subject to specific requirements for caution and specialized medical monitoring.


Q: What does 'contraindicated' mean in the context of Hytisone?

A medicine is contraindicated when it must not be used in patients with a specific condition. For Hytisone, this includes conditions like systemic fungal infections or known hypersensitivity to the drug, because the risks of use outweigh any potential therapeutic benefit.


Q: Does Hytisone have drug-drug interaction warnings with common heart medications?

Yes. Regulatory documentation specifically identifies the potential for interaction with Potassium-Depleting Agents. These agents, which include some diuretics used for heart conditions, may increase the risk of developing low potassium levels (hypokalemia).


Q: Are there known environmental factors that affect Hytisone's use?

Yes. Official product information contains specific storage requirements to maintain the medicine's stability. These requirements indicate that Hytisone should be stored at a Controlled Room Temperature (typically 20 C to 25 C), protected from light and moisture, and should not be frozen.

How should Hytisone be stored and disposed of?

How to Store and Dispose of Hytisone

Storage of Hytisone (Hydrocortisone) must strictly follow the conditions specified in official regulatory labeling to ensure product stability.

Required Storage Conditions

Hytisone must be stored at Controlled Room Temperature, typically between 20°C and 25°C (68°F and 77°F). The product must be protected from light and excessive moisture and must not be frozen. To maintain product integrity, keep the medication in the original container and ensure it is tightly closed when not in use. For safety, the product must be stored out of the reach and sight of children.

Official Disposal Instructions

Do not dispose of unused or expired Hytisone by flushing it down the toilet or placing it in a drain. Disposal should be managed through an official drug take-back program or community collection site. If a collection site is unavailable, the product must be mixed with an unpalatable substance and sealed before being placed in household trash, following specific governmental guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hytisone found in:

A-Z Index: